Acute Porphyria Drug Database

Monograph

A02BD08 - Bismuth Subcitrate, Tetracycline and Metronidazole
Propably not porphyrinogenic
PNP

Rationale
Bismuth subcitrate, tetracycline and metronidazole are all classified as probably not porphyrinogenic, and therefore this combination product is also regarded probably not porphyrinogenic. For details of the characteristics of each substance and the rationale behind the classifications, please search the individual substances bismuth subcitrate (ATC A02BX05), tetracycline (ATC J01AA07) and metronidazole (J01XD01) in this database.

Similar drugs
Explore alternative drugs in similar therapeutic classes A02B / A02BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Tryplera · Tryplera 140 mg - 125 mg - 125 mg gél.
United Kingdom
Pylera · Pylera 140mg/125mg/125mg capsules
Poland
Pylera
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙